Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry May 28, 2024 Comments off Read More
SuFEx-based chemical diversification for the systematic discovery of CRBN molecular glues April 9, 2024 Comments off Fun collaboration with Dr. Michael Erb & Dr. K. B. Sharpless at Scripps. We love SuFEx! https://www.sciencedirect.com/science/article/pii/S0968089624001135 Read More